Leydig insulin-like protein

Subscribe to Selected New Research on Leydig insulin-like protein

9 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: member of the insulin-like hormone superfamily; from testis & kidney; amino acid residue signal peptide; MW 6.25 kDa; amino acid sequence in first source; GenBank X58369; RefSeq NM_005543 (human)

Also Known As:

INSL3 protein; INSL3 protein, human; INSL5 protein; Insl3 protein, mouse; Insl3 protein, rat; Insulin-like 3 protein, mouse; Insulin-like 3 protein, rat; Insulin-like peptide 5; Ley I-L protein; Ley-I-L protein, human; Ley-I-L protein, mouse; Ley-I-L protein, rat; Leydig insulin-like protein, mouse; RLF (LEY I-L); RLNL protein, human; Relaxin-Insulin-like factor, RIF2; Relaxin-insulin-like factor 2; insulin-like 3 (Leydig cell) protein, human; relaxin-like factor; relaxin-like factor protein, human; relaxin-like factor protein, mouse; relaxin-like factor protein, rat

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists

Hormones: 46253

Peptide Hormones: 377

Pancreatic Hormones: 79

Proinsulin: 648

Insulin: 57580

Leydig insulin-like protein: 9

Amino Acids, Peptides, and Proteins

Proteins: 58433

Leydig insulin-like protein: 9

Peptides: 16375

Peptide Hormones: 377

Pancreatic Hormones: 79

Proinsulin: 648

Insulin: 57580

Leydig insulin-like protein: 9

Experts

1.	Büllesbach, Erika E: 1 article (03/2008)
2.	Schwabe, Christian: 1 article (03/2008)
3.	Fullbright, George: 1 article (03/2008)
4.	Boockfor, Fredric R: 1 article (03/2008)
5.	Shamay, Avi: 1 article (09/2005)
6.	Shahar, Ron: 1 article (09/2005)
7.	Ranen, Eyal: 1 article (09/2005)
8.	Stein, Uri: 1 article (09/2005)
9.	Merchav, Ronit: 1 article (09/2005)
10.	Feuermann, Yonatan: 1 article (09/2005)

Related Diseases

1.	Cryptorchidism (Undescended Testes) 03/01/2008 - "Cryptorchidism induced in normal rats by the relaxin-like factor inhibitor." 04/01/2000 - "A common polymorphism in the human relaxin-like factor (RLF) gene: no relationship with cryptorchidism." 10/01/2005 - "Because in utero exposure to di (n-butyl) phthalate (DBP) induces cryptorchidism and suppresses Insl3 gene expression, we investigated Insl3 protein expression in fetal and adult rats exposed to 500 mg/kg.d DBP from E13.5 to E21.5. Expression on E17.5 and E19.5 decreased dramatically after DBP exposure, but there was no consistent correlation between this suppression and abnormal testis position. " 11/01/2000 - "Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism." Order ALL the reference details at left...
2.	Sertoli-Leydig Cell Tumor 09/01/1999 - "Relaxin-like factor expression in a human ovarian Sertoli-Leydig cell tumor." Order ALL the reference details at left...
3.	Neoplasms (Cancer) 11/20/2003 - "The members of the relaxin-like hormone family, relaxin and INSL3, also known as relaxin-like factor (RLF) or Leydig cell-derived insulin-like factor (LEY-I-L), are implicated in various mechanisms associated with tumor cell growth, differentiation, invasion and neovascularization. " Order ALL the reference details at left...
4.	Infertility (Sterility) 12/01/2001 - "Deletion of the relaxin-like factor (RLF) gene in mice causes retention of testicles and infertility. " Order ALL the reference details at left...
5.	Hernia (Hernias) 09/01/2005 - "OBJECTIVES: To compare the expression of canine relaxin, relaxin-like factor (RLF), and relaxin receptors within the muscles of the pelvic diaphragm of dogs with perineal hernia (PH) and clinically normal dogs. " 09/01/2005 - "Expression of relaxin receptor LRG7, canine relaxin, and relaxin-like factor in the pelvic diaphragm musculature of dogs with and without perineal hernia." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Relaxin
2.	Insulin (Novolin)
3.	Testosterone (Sustanon)
4.	Messenger RNA (mRNA)
5.	Hormones
6.	Dibutyl Phthalate (Butyl Phthalate)
7.	relaxin receptors

Best Treatments:
Research Summary Report
on Cryptorchidism

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 23 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>